BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38326222)

  • 1. Dermatologic manifestations in pediatric patients with inflammatory bowel disease.
    Afarideh M; Bartoletta K; Tollefson MM
    Pediatr Dermatol; 2024; 41(2):234-242. PubMed ID: 38326222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatologic manifestations in inflammatory bowel disease in Tunisia.
    Mebazaa A; Aounallah A; Naija N; Cheikh Rouhou R; Kallel L; El Euch D; Boubaker J; Mokni M; Filali A; Ben Osman A
    Tunis Med; 2012 Mar; 90(3):252-7. PubMed ID: 22481199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology.
    Schneeweiss MC; Kirchgesner J; Wyss R; Jin Y; York C; Merola JF; Mostaghimi A; Silverberg JI; Schneeweiss S; Glynn RJ
    Br J Dermatol; 2022 Nov; 187(5):692-703. PubMed ID: 35718888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence and risk factors of extraintestinal manifestations in children with inflammatory bowel disease].
    Shan CY; Zhang QQ; Xiao Y; Wang XQ; Yu Y; Xu X; Xu CD
    Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):694-699. PubMed ID: 31530355
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics and trends in the incidence of inflammatory bowel disease in Korean children: a single-center experience.
    Kim BJ; Song SM; Kim KM; Lee YJ; Rhee KW; Jang JY; Park SJ; Yoon CH
    Dig Dis Sci; 2010 Jul; 55(7):1989-95. PubMed ID: 19763825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of cutaneous manifestations and related factors in patients with ulcerative colitis].
    Tian Y; Li JX; Wang HH; Li RY; Liu XG
    Zhonghua Nei Ke Za Zhi; 2016 Jul; 55(7):505-9. PubMed ID: 27373283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP
    Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
    Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J
    Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intestinal complications and extraintestinal manifestations in children with inflammatory bowel disease].
    Stawarski A; Iwańczak B; Krzesiek E; Iwańczak F
    Pol Merkur Lekarski; 2006 Jan; 20(115):22-5. PubMed ID: 16617729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.
    Juliao-Baños F; Kock J; Arrubla M; Calixto O; Camargo J; Cruz L; Hurtado J; Clavijo A; Donado J; Schwartz S; Abreu MT; Damas OM
    Medicine (Baltimore); 2021 Feb; 100(7):e24729. PubMed ID: 33607817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
    King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
    Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous and mucosal manifestations of inflammatory bowel diseases].
    Károlyi Z; Erós N; Ujszászy L; Nagy G
    Orv Hetil; 2000 Jun; 141(25):1391-5. PubMed ID: 10934882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirty-year Trend in Inflammatory Bowel Disease on Jeju Island, South Korea.
    Kim JW; Song HJ; Boo SJ; Kim HU; Kang KS; Na SY
    Korean J Gastroenterol; 2023 Jun; 81(6):243-252. PubMed ID: 37350519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum and trend of pediatric inflammatory bowel disease: A two-decade experience from northern India.
    Mohan N; Deswal S; Bhardwaj A
    Indian J Gastroenterol; 2024 Feb; 43(1):208-214. PubMed ID: 37943479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of perianal disease in young patients with inflammatory bowel disease.
    Zwintscher NP; Shah PM; Argawal A; Chesley PM; Johnson EK; Newton CR; Maykel JA; Steele SR
    Int J Colorectal Dis; 2015 Sep; 30(9):1275-9. PubMed ID: 25994782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of clinical characteristics and drug treatment of inflammatory bowel disease in children: a single center study].
    Zhang R; Zhong XM; Gong YZ; Ma X; Zhu D; Ning HJ; Wang FP; Zou JZ; Zhang YL
    Zhonghua Er Ke Za Zhi; 2020 Jul; 58(7):570-575. PubMed ID: 32605341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.